Effects of low dose tamoxifen on normal breast tissue from premenopausal women
- 1 May 2003
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (7) , 891-898
- https://doi.org/10.1016/s0959-8049(02)00530-0
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The clinical significance of error measurement in the interpretation of treatment resultsEuropean Journal of Orthodontics, 2001
- Risk and prognosis of endometrial cancer after tamoxifen for breast cancerThe Lancet, 2000
- Breast Cancer Prevention by AntiestrogensAnnals of the New York Academy of Sciences, 1999
- Effect of Blood Tamoxifen Concentrations on Surrogate Biomarkers in a Trial of Dose Reduction in Healthy WomenJournal of Clinical Oncology, 1999
- Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy womenEuropean Journal Of Cancer, 1999
- Biologic Activity of Tamoxifen at Low Doses in Healthy WomenJNCI Journal of the National Cancer Institute, 1998
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary MalignanciesJNCI Journal of the National Cancer Institute, 1995
- Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *JNCI Journal of the National Cancer Institute, 1994